Sidebar: New Ways To Separate Enantiomers
![]() INTRICATE ROLES: Louisiana State's Isiah Warner notes that determining the side effects of enantiomers is not always a straightforward task. |
Developing racemic (mixed-enantiomer) drugs is on the way out, industry analysts say, because pharmaceutical companies must evaluate the individual enantiomers and the combination. "Nearly every pharmaceutical company we deal with doesn't even talk about using a racemate, because it costs more to develop. The company has to put three products through clinical trials, not one," explains Roger Pettman, vice president for sales ...